[Study of the respiratory tolerance of adrenolytic beta-blockers in the asthmatic].
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D000328:Adult; D001249:Asthma / Q000188:drug therapy*; D001262:Atenolol / Q000009:adverse effects; D001986:Bronchial Spasm / Q000139:chemically induced; D005260:Female; D005541:Forced Expiratory Volume; D006801:Humans; D008297:Male; D010869:Pindolol / Q000009:adverse effects; D011217:Practolol / Q000009:adverse effects; D011433:Propranolol / Q000009:adverse effects; D012119:Respiration / Q000187:drug effects*; D014797:Vital Capacity / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D001262:Atenolol; D011433:Propranolol; D010869:Pindolol; D011217:Practolol
Etude de la tolérance respiratoire des adrénolytiques beta-bloqueurs chez l'asthmatique.